155 related articles for article (PubMed ID: 17854826)
1. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.
Sung MM; Schulz CG; Wang W; Sawicki G; Bautista-López NL; Schulz R
J Mol Cell Cardiol; 2007 Oct; 43(4):429-36. PubMed ID: 17854826
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.
Wang W; Sawicki G; Schulz R
Cardiovasc Res; 2002 Jan; 53(1):165-74. PubMed ID: 11744025
[TBL] [Abstract][Full Text] [Related]
3. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.
Sawicki G; Leon H; Sawicka J; Sariahmetoglu M; Schulze CJ; Scott PG; Szczesna-Cordary D; Schulz R
Circulation; 2005 Jul; 112(4):544-52. PubMed ID: 16027249
[TBL] [Abstract][Full Text] [Related]
4. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.
Gao CQ; Sawicki G; Suarez-Pinzon WL; Csont T; Wozniak M; Ferdinandy P; Schulz R
Cardiovasc Res; 2003 Feb; 57(2):426-33. PubMed ID: 12566115
[TBL] [Abstract][Full Text] [Related]
6. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
[TBL] [Abstract][Full Text] [Related]
7. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.
Ali MA; Cho WJ; Hudson B; Kassiri Z; Granzier H; Schulz R
Circulation; 2010 Nov; 122(20):2039-47. PubMed ID: 21041693
[TBL] [Abstract][Full Text] [Related]
8. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.
Polewicz D; Cadete VJ; Doroszko A; Hunter BE; Sawicka J; Szczesna-Cordary D; Light PE; Sawicki G
J Cell Mol Med; 2011 May; 15(5):1136-47. PubMed ID: 20518849
[TBL] [Abstract][Full Text] [Related]
9. Cardiac function is not significantly diminished in hearts isolated from young caveolin-1 knockout mice.
Chow AK; Daniel EE; Schulz R
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1183-9. PubMed ID: 20693397
[TBL] [Abstract][Full Text] [Related]
10. Activation of α1B-adrenoceptors contributes to intermittent hypobaric hypoxia-improved postischemic myocardial performance via inhibiting MMP-2 activation.
Gao L; Chen L; Lu ZZ; Gao H; Wu L; Chen YX; Zhang CM; Jiang YK; Jing Q; Zhang YY; Yang HT
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(11):H1569-81. PubMed ID: 24705558
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
[TBL] [Abstract][Full Text] [Related]
13. Influence of ischemia/reperfusion and modulation of PI3K/Akt kinase pathway on matrix metalloproteinase-2 in rat hearts.
Spániková A; Ivanová M; Matejíková J; Ravingerová T; Barancík M
Gen Physiol Biophys; 2010 Mar; 29(1):31-40. PubMed ID: 20371878
[TBL] [Abstract][Full Text] [Related]
14. Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium.
Rork TH; Hadzimichalis NM; Kappil MA; Merrill GF
J Mol Cell Cardiol; 2006 Apr; 40(4):553-61. PubMed ID: 16530785
[TBL] [Abstract][Full Text] [Related]
15. Nuclear matrix metalloproteinase-2 in the cardiomyocyte and the ischemic-reperfused heart.
Baghirova S; Hughes BG; Poirier M; Kondo MY; Schulz R
J Mol Cell Cardiol; 2016 May; 94():153-161. PubMed ID: 27079252
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 proteolyzes mitofusin-2 and impairs mitochondrial function during myocardial ischemia-reperfusion injury.
Bassiouni W; Valencia R; Mahmud Z; Seubert JM; Schulz R
Basic Res Cardiol; 2023 Jul; 118(1):29. PubMed ID: 37495895
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.
Chan BYH; Roczkowsky A; Moser N; Poirier M; Hughes BG; Ilarraza R; Schulz R
Can J Physiol Pharmacol; 2018 Dec; 96(12):1238-1245. PubMed ID: 30308129
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
[TBL] [Abstract][Full Text] [Related]
19. Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2.
Cadete VJ; Sawicka J; Jaswal JS; Lopaschuk GD; Schulz R; Szczesna-Cordary D; Sawicki G
FEBS J; 2012 Jul; 279(13):2444-54. PubMed ID: 22564771
[TBL] [Abstract][Full Text] [Related]
20. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury.
Wang W; Schulze CJ; Suarez-Pinzon WL; Dyck JR; Sawicki G; Schulz R
Circulation; 2002 Sep; 106(12):1543-9. PubMed ID: 12234962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]